Navigation Links
TGen breast cancer research benefits from $3.5 million Komen award
Date:9/23/2011

tients with triple-negative breast cancer so often fail to respond to available therapies, and to design new ways to more effectively treat this difficult form of cancer."

Dr. Wicha, M.D., Distinguished Professor of Oncology and Director of the U-M Comprehensive Cancer Center, was one of the first to identify cancer "stem cells" in solid tumors, recognizing them in breast cancer tissue in 2003. Cancer stem cells are the small number of cells within a tumor that continually fuel the tumor's growth and spread, rendering the tumor resistent to today's therapies. Many researchers believe traditional chemotherapy and radiation treatments often become ineffective because they do not kill the cancer stem cells, and that the key to future treatments is to develop drugs that target and kill these cells. Research suggests that triple-negative breast cancers have a higher proportion of cancer stem cells.

Among women with breast cancer, triple negative breast cancer represents about 15 percent of diagnoses in Caucasian American women, but 26 percent in African American women and up to 82 percent in west African women. The grant proposal includes studying tumor cells from African and African-American women to look for molecular differences in triple-negative tumors. Laboratory research will look at whether targeting the breast cancer stem cells has an impact on these tumors.

"Through this research study, we will be able to provide key insights into whether or not cancer stem cells plays a role in the significant differences observed in death rates among women of west African origin who are more likely to be diagnosed with, and die from, this terrible form of cancer," said Dr. Heather Cunliffe, Head of TGen's Breast & Ovarian Cancer and a co-investigator on the study.

Researchers also plan to launch at least three clinical trials to investigate new treatments that target cancer stem cells. Based on the results of these trials, a larger r
'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Breast cancer treatment resistance linked to signaling pathway
2. The dietary supplement genistein can undermine breast cancer treatment
3. Breast cancer cells recycle to escape death by hormonal therapy
4. Second lumpectomy for breast cancer reduces survival rates
5. Study looks at psychological impact of gene test for breast cancer
6. SNM releases new fact sheet on breast cancer and molecular imaging
7. Study links nicotine with breast cancer growth and spread
8. UC Davis researchers discover a key to aggressive breast cancer
9. CTRC-AACR San Antonio Breast Cancer Symposium
10. Einstein researchers develop a new way to study how breast cancer spreads
11. Mayo researchers identify dangerous two-faced protein crucial to breast cancer spread and growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2014)... patients referred for evaluation of suspected genetic conditions, ... 25 percent, including detection of a number of ... disease, according to a study appearing in ... coincide with the American Society of Human Genetics ... or coding regions of thousands of genes simultaneously ...
(Date:10/17/2014)... . Why do ... to reproduce? And why are there two sexes anyway? These ... of the research journal Molecular Human Reproduction published ... Bielefeld University Bielefeld has compiled this special issue on sperm ... to copulate with several males in quick succession – chimpanzees ...
(Date:10/16/2014)... on the human body. Battles are won, lost ... cancer, this stalemate—known as tumor dormancy—can last up ... phenomena that is poorly understood. , A ... Salvatore Torquato, a Professor of Chemistry at Princeton ... dormancy and the switch to a malignant state. ...
Breaking Biology News(10 mins):Whole-exome sequencing shows potential as diagnostic tool 2Sperm wars 2Modeling tumor dormancy 2
... French . , Leishmania is a deadly ... than 2 million new cases reported every year. Until recently, scientists ... mystery has now been solved according to a new study published ... Martin Olivier a scientist at the Research Institute of the ...
... who eat excessive quantities of liquorice during pregnancy could ... has shown. A study of eight year old ... pregnant found they did not perform as well as ... more likely to have poor attention spans and show ...
... allergy. Cathleen Muche-Borowski and her coauthors present a clinical ... of Deutsches rzteblatt International (Dtsch Arztebl Int ... common in Western industrialized countries. As there is still ... or atopic eczema, the prevention of these diseases is ...
Cached Biology News:Major discovery opens door to leishmania treatment 2Eating liquorice in pregnancy may affect a child's IQ and behavior 2
(Date:10/20/2014)... Oct. 20, 2014 PureTech , a ... big healthcare problems, announced today the closing of ... participation from Invesco Perpetual, a $120 Billion group ... drive PureTech,s existing pipeline forward and to advance ... the scientific creativity to really go for the ...
(Date:10/20/2014)... Local veterinary surgeon, Dr. Tim McCarthy is seeking ... stem cells for dogs with osteoarthritis. Dr. McCarthy has ... clinical stem cell therapy for 7 years. The ultimate ... single injection of donor stem cells into one or ... inflammation in the treated joints. , Candidates for ...
(Date:10/19/2014)... CAMBRIDGE, Mass. , Oct. 19, 2014 NextCODE ... of the whole genome in real time, today announced the ... the NextCODE Exchange , at the American Society of ... . To learn more, sign up and apply for ... on its unique features and benefits can be viewed ...
(Date:10/19/2014)... The Asia-Pacific Speech Analytics market report ... with analysis and forecast of revenue. This market is ... $208 million by 2019, at a Compound Annual Growth ... Browse through the TOC of the Asia-Pacific Speech Analytics ... analysis provided. It also provides a glimpse of the ...
Breaking Biology Technology:PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 2The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 2The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 4
... Data to be presented at American Society of Anesthesiologists Annual ... continuous hemoglobin (SpHb) and Oxygen Content (SpOC) monitor with ... ... Calif., Oct. 17 Masimo, the inventor,of Pulse CO-Oximetry(TM) and ...
... announced today a significant redesign of its web site, including ... database of published synthetic gene applications and a revamped Bioinformatics ... DNA and protein sequences. , ... ...
... Shandong, China, Oct. 17 /Xinhua-PRNewswire-FirstCall/ --,Shengtai Pharmaceutical, ... Company,), a leading manufacturer and distributor of ... announced that it has,completed factory improvements providing ... cornstarch facility., The Company,s improvement of ...
Cached Biology Technology:Five New Clinical Studies Show Value of Masimo PVI & PI 2Five New Clinical Studies Show Value of Masimo PVI & PI 3Five New Clinical Studies Show Value of Masimo PVI & PI 4Five New Clinical Studies Show Value of Masimo PVI & PI 5DNA2.0 Launches New Website: Enhanced Design and Free Bioinformatics Tools Demonstrate DNA2.0's Customer Focus 2Shengtai Pharmaceutical Completes Factory Improvements Resulting in Operational and Environmental Benefits 2Shengtai Pharmaceutical Completes Factory Improvements Resulting in Operational and Environmental Benefits 3
...
... Signet offers the most comprehensive, cost-effective ... We have incorporated unprecedented quality into ... This includes proven detection chemistries and ... the TechMate protocol. It also includes ...
... Resistant (X/R) Red System consists of ... Activator and X/R Red Buffer. The ... phosphatase to produce red staining that ... Contains:, , Buffer, 100 mL , ...
Human Cell Line Slides...
Biology Products: